For the year ending 2025-12-31, RGNX has $453,032K in assets. $350,299K in debts. $34,466K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 34,466 | |||
| Marketable securities | 195,604 | |||
| Accounts receivable | 26,379 | |||
| Prepaid expenses | 11,927 | |||
| Other current assets | 12,905 | |||
| Total current assets | 281,281 | |||
| Marketable securities | 10,785 | |||
| Accounts receivable | 2,312 | |||
| Total property and equipment | 192,047 | |||
| Accumulated depreciation and amortization | 87,192 | |||
| Property and equipment, net | 104,855 | |||
| Operating lease right-of-use assets | 47,156 | |||
| Restricted cash | 2,030 | |||
| Other assets | 4,613 | |||
| Total assets | 453,032 | |||
| Accounts payable | 21,358 | |||
| Accrued expenses and other current liabilities | 38,390 | |||
| Deferred revenue | 10,452 | |||
| Operating lease liabilities | 8,286 | |||
| Royalty monetization liabilities | 39,609 | |||
| Total current liabilities | 118,095 | |||
| Deferred revenue | 18,943 | |||
| Operating lease liabilities | 65,215 | |||
| Royalty monetization liabilities | 147,408 | |||
| Other liabilities | 638 | |||
| Total liabilities | 350,299 | |||
| Common stock 0.0001 par value 100,000 shares authorized at december 31, 2025 and 2024 50,892 and 49,549 shares issued and outstanding at december 31, 2025 and 2024, respectively | 5 | |||
| Additional paid-in capital | 1,229,442 | |||
| Accumulated other comprehensive loss | -687 | |||
| Accumulated deficit | -1,126,027 | |||
| Total stockholders equity | 102,733 | |||
| Total liabilities and stockholders equity | 453,032 | |||
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)